Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04787692 · ClinicalTrials.gov registry record · NA
Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines.
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT04787692 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 150 participants.
The verdict
NCT04787692, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the safety, acceptability, and feasibility of a controlled taper off of opioids and/or benzodiazepines, with the use of behavioral health tele-health based therapy services, in the perioperative patient.
Interventions
- BEHAVIORAL Opioid and Benzodiazepine Naive-patients
- BEHAVIORAL Opioid and Benzodiazepine Tolerant-patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04787692
The ClinicalTrials.gov registry entry for NCT04787692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Opioid and Benzodiazepine Naive-patients is the first listed.
NCT04787692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04787692 about?
NCT04787692 is a clinical study titled "Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines.". The purpose of this study is to examine the safety, acceptability, and feasibility of a controlled taper off of opioids and/or benzodiazepines, with the use of behavioral health tele-health based therapy services, in the perioperative patient.
What is the current status of trial NCT04787692?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-08-07. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04787692?
The interventions under investigation include: Opioid and Benzodiazepine Naive-patients (BEHAVIORAL), Opioid and Benzodiazepine Tolerant-patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT04787692?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.